CollPlant BiotechnologiesCLGN -2.46%35 Days Payable is 179.76 as of Mar. 2026, which is 7% below its 10-year median of 193.68. GuruFocus rates CLGN with a GF Score™ of 35/100 and a GF Value™ of $0.29 (Modestly Overvalued). The stock has 4 warning signs investors should review. Among 704 Biotechnology companies, CollPlant Biotechnologies ranks better than 66.76% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, CollPlant Biotechnologies's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CollPlant Biotechnologies Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, CollPlant Biotechnologies's Days Payable distribution charts can be found below:
* The bar in red indicates where CollPlant Biotechnologies's Days Payable falls into.
CollPlant Biotechnologies Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
CollPlant Biotechnologies's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CollPlant Biotechnologies (CLGN) has a Days Payable of 179.76 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on CollPlant Biotechnologies and its competitors. This is near median its historical median of 193.68. Over the past decade, CollPlant Biotechnologies' Days Payable has ranged from 99.15 to 8,326.56. According to the industry distribution chart, CollPlant Biotechnologies ranks #234 out of 704 companies in the Biotechnology industry, placing it in the top 33.2%.
Is CollPlant Biotechnologies' Days Payable too high?
CollPlant Biotechnologies' current Days Payable of 179.76 is near median its 10-year median of 193.68. Over the past 10 years, this metric has ranged from a low of 99.15 to a high of 8,326.56. The Biotechnology industry median Days Payable is 113.56. CollPlant Biotechnologies' value of 179.76 is 58.3% above this industry median. Based on the distribution chart, CollPlant Biotechnologies ranks #234 out of 704 companies in the Biotechnology industry, which is above the industry midpoint. Overall, CollPlant Biotechnologies has a GF Score™ of 35/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does CollPlant Biotechnologies' Days Payable compare to CPMV and TCRT?
According to the Biotechnology industry distribution chart, CollPlant Biotechnologies ranks #234 out of 704 companies for Days Payable. This puts CollPlant Biotechnologies in the upper half of its industry. The industry median Days Payable is 113.56. CollPlant Biotechnologies' value of 179.76 is 58.3% above this benchmark. Historically, CollPlant Biotechnologies' own Days Payable has ranged from 99.15 to 8,326.56 over the past decade. While the company's 10-year median is 193.68 vs. the industry median of 113.56, CollPlant Biotechnologies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 113.56, based on 704 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CollPlant Biotechnologies's current Days Payable of 179.76 is 58.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on CollPlant Biotechnologies and its competitors. For the Biotechnology industry, the median Days Payable is 113.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CollPlant Biotechnologies's current Days Payable is 179.76, which is near median its own 10-year median of 193.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CollPlant Biotechnologies stock overvalued right now?
Based on GuruFocus' analysis, CollPlant Biotechnologies (CLGN) is currently considered Modestly Overvalued. The stock's GF Value™ is $0.29, compared to a current price of $0.34 — trading 17.3% above its estimated fair value. The current Days Payable is 179.76, which is near median its 10-year median of 193.68 and 58.3% above the Biotechnology industry median of 113.56. CollPlant Biotechnologies' overall GF Score™ is 35/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For CollPlant Biotechnologies (CLGN), the current Days Payable is 179.76 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CollPlant Biotechnologies (CLGN) Overvalued in 2026?
Based on GuruFocus' analysis, CollPlant Biotechnologies stock appears to be overvalued.
The current stock price of $0.34 is trading 17.3% above its estimated GF Value™ of $0.29.
GuruFocus considers CollPlant Biotechnologies to be Modestly Overvalued.
Key valuation signals for CLGN:
Days Payable: 179.76 (near median its 10-year median of 193.68)
GF Value™: $0.29 vs. price of $0.34 (17.3% above fair value)
Industry Position: 58.3% above the Biotechnology median (#234 of 704)
No single metric tells the full story. See the CLGN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives majority revenue, Canada, Europe and Other, and Israel.
35GF Score
Get the complete analysis for CLGN
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CLGN has been successfully added to your 
